Growing evidence has demonstrated that GPR55 is overexpressed in numerous malignancies, including breast [68,69] and colorectal cancers [57,59], endometrial [111] and squamous cell carcinomas [112]. The gene discussed is GPR55; the disease is colorectal cancer.